The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations

Documenti analoghi

• The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations
  di: Vaishnaw, Akshay K., et al.
  Pubblicazione: (1999)
• Two CD95 (APO-1/Fas) signaling pathways.
  di: Scaffidi, C, et al.
  Pubblicazione: (1998)
• Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase
  Pubblicazione: (1994)
• Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia
  di: Martin, David A., et al.
  Pubblicazione: (1999)
• Alterations of Fas (Apo-1/CD95) Gene in Cutaneous Malignant Melanoma
  di: Shin, Min Sun, et al.
  Pubblicazione: (1999)